0
Your cart

Your cart is empty

Books > Science & Mathematics > Biology, life sciences > Microbiology (non-medical)

Buy Now

Preclinical Evaluation of Antimicrobial Nanodrugs (Paperback, 1st ed. 2020) Loot Price: R2,789
Discovery Miles 27 890
Preclinical Evaluation of Antimicrobial Nanodrugs (Paperback, 1st ed. 2020): Juan Bueno

Preclinical Evaluation of Antimicrobial Nanodrugs (Paperback, 1st ed. 2020)

Juan Bueno

Series: Nanotechnology in the Life Sciences

 (sign in to rate)
Loot Price R2,789 Discovery Miles 27 890 | Repayment Terms: R261 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

Translational medicine addresses the gap between research and the clinical application of new discoveries. To efficiently deliver new drugs to care centers, a preclinical evaluation, both in vitro and in vivo, is required to ensure that the most active and least toxic compounds are selected as well as to predict clinical outcome. Antimicrobial nanomedicines have been shown to have higher specificity in their therapeutic targets and the ability to serve as adjuvants, increasing the effectiveness of pre-existing immune compounds. The design and development of new standardized protocols for evaluating antimicrobial nanomedicines is needed for both the industry and clinical laboratory. These protocols must aim to evaluate laboratory activity and present models of pharmacokinetic-pharmacodynamic and toxicokinetic behavior that predict absorption and distribution. Likewise, these protocols must follow a theranostics approach, be able to detect promising formulations, diagnose the infectious disease, and determine the correct treatment to implement a personalized therapeutic behavior. Given the possibilities that nanotechnology offers, not updating to new screening platforms is inadequate as it prevents the correct application of discoveries, increasing the effect of the valley of death between innovations and their use. This book is structured to discuss the fundamentals taken into account for the design of robust, reproducible and automatable evaluation platforms. These vital platforms should enable the discovery of new medicines with which to face antimicrobial resistance (RAM), one of the great problems of our time.

General

Imprint: Springer Nature Switzerland AG
Country of origin: Switzerland
Series: Nanotechnology in the Life Sciences
Release date: May 2021
First published: 2020
Authors: Juan Bueno
Dimensions: 235 x 155mm (L x W)
Format: Paperback
Pages: 117
Edition: 1st ed. 2020
ISBN-13: 978-3-03-043857-9
Categories: Books > Professional & Technical > Technology: general issues > Nanotechnology
Books > Medicine > Other branches of medicine > Pathology > Medical microbiology & virology
Books > Science & Mathematics > Biology, life sciences > Microbiology (non-medical) > General
Books > Professional & Technical > Industrial chemistry & manufacturing technologies > Industrial chemistry > Pharmaceutical technology
Books > Science & Mathematics > Biology, life sciences > Botany & plant sciences > Plant reproduction & propagation > General
LSN: 3-03-043857-0
Barcode: 9783030438579

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners